Survey of Hospitals Quantifies Flu Vaccine Price Gouging

Article

The American Society of Health-System Pharmacists has conducted a survey of more than 2,800 hospital pharmacy directors in the U.S. about how the flu vaccine shortage is affecting their ability to care for patients.

 

As of Oct. 12, 2004 nearly 650 pharmacy directors have responded. The survey will continue through midnight today.

 

Preliminary findings include:

 

-- In just the few days since the influenza vaccine shortage was announced, more than 55 percent of respondents report that they have been contacted by opportunistic vendors offering to sell flu vaccine at highly inflated prices.

 

Of the hospitals contacted by opportunistic vendors:

 

- - More than 80 percent report being offered the vaccine at more than four times the original market value.

 

- - Nearly 20 percent have been offered the vaccine at $800 or more per 10-dose vial -- more than 10 times the original market value

 

- More than 75 percent of hospitals report that they will not have enough flu vaccine to meet the vaccination recommendations of the Centers for Disease Control and Prevention (CDC).

 

Source: American Society of Health-System Pharmacists (ASHP)    

 

Recent Videos
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Related Content